Cabot (NYSE:CBT) Issues FY 2027 Earnings Guidance

Key Points

• Cabot issued FY 2027 EPS guidance of $6.15–$6.75, below the analyst consensus estimate of $7.03.
• Cabot’s latest quarterly results exceeded expectations, with EPS of $1.61 versus $1.55 expected and revenue of $1.01 billion, up 12.2% year over year.
• Analyst sentiment remains cautious, with Cabot carrying an average “Hold” rating and an $87.80 target price; insiders have also sold approximately $19.6 million of stock over the past 90 days.

Cabot (NYSE:CBT - Get Free Report) updated its FY 2027 earnings guidance on Tuesday morning. The company provided EPS guidance of 6.150-6.750 for the period, compared to the consensus earnings per share estimate of 7.030.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on CBT shares. UBS Group cut their target price on shares of Cabot from $92.00 to $86.00 and set a "neutral" rating on the stock in a research report on Monday, October 5th. Weiss Ratings reissued a "hold (c)" rating on shares of Cabot in a report on Friday, August 21st. Truist Financial set a $100.00 price target on shares of Cabot in a research report on Wednesday, August 5th. Wall Street Zen raised shares of Cabot from a "hold" rating to a "buy" rating in a research note on Sunday, October 11th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Cabot from $70.00 to $78.00 and gave the stock an "underweight" rating in a report on Friday, August 7th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Cabot presently has an average rating of "Hold" and an average target price of $87.80.

Cabot Price Performance

Shares of CBT opened at $75.64 on Tuesday. Cabot has a 52-week low of $58.33 and a 52-week high of $94.53. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. The business's 50 day moving average price is $77.79 and its two-hundred day moving average price is $79.52. The firm has a market cap of $3.90 billion, a PE ratio of 21.31, a price-to-earnings-growth ratio of 8.68 and a beta of 0.83.

Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings results on Monday, November 2nd. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.55 by $0.06. The firm had revenue of $1.01 billion for the quarter, compared to analysts' expectations of $927.29 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%. The company's revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the prior year, the business earned $1.70 EPS. On average, equities analysts anticipate that Cabot will post 6.35 EPS for the current year.

Insider Transactions at Cabot

In other Cabot news, CEO Sean Keohane sold 134,895 shares of the firm's stock in a transaction on Friday, August 28th. The shares were sold at an average price of $85.00, for a total value of $11,466,075.00. Following the completion of the sale, the chief executive officer directly owned 404,134 shares in the company, valued at approximately $34,351,390. This trade represents a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders have sold 229,597 shares of company stock worth $19,646,746 over the last 90 days. 3.08% of the stock is owned by corporate insiders.

About Cabot

Cabot Corporation NYSE: CBT is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot's products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.